Skip to main content
. 2020 Mar 10;10:4446. doi: 10.1038/s41598-020-61441-0

Figure 8.

Figure 8

Schematic illustration of the timeline for the assessment of the effects of hUCBCs in ameliorating mouse brain lesions and behavioural outcomes. Postnatal day 7 (P7) ICR mice were conditioned for hypoxic-ischaemic brain injury. Intraperitoneal cyclosporine was administered to the hUCBC group and cyclosporine-only group beginning on P13 for 5 consecutive days (small arrows). At P14, the hUCBC group received hUCBCs (3 × 107/kg) intraperitoneally, whereas IL-8 group received IL-8 (50 µg/kg) intraperitoneally. For long-term follow-up, mice were allocated to the sham, HI, cyclosporine, hUCBC, and IL-8 groups. At P21, the sham, HI, hUCBC, and IL-8 groups were assessed for angiogenesis via IHC. At P42, behavioural test of the mice was performed prior to sacrifice. Sacrifice A: sacrifice schedule for inhibition tests; Sacrifice B: for IHC and behavioural studies; HI, hypoxic-ischaemic brain injury; hUCBC, human umbilical cord blood mononuclear cells; IHC, immunohistochemistry.